Oh Young Bang | Neuroscience | Best Researcher Award

Posted on by Forensic Scientist

Prof. Oh Young Bang | Neuroscience | Best Researcher Award

SAMSUNG MEDICAL CENTER | SOUTH KOREA

Prof. Oh Young Bang is a renowned neurologist and biomedical researcher, currently serving as a Professor in the Department of Neurology at Samsung Medical Center, affiliated with Sungkyunkwan University School of Medicine, Seoul, Korea. He also holds a professorship at the Samsung Advanced Institute for Health Sciences and Technology. In addition to his academic roles, he is the CEO of S&E Bio, a pioneering biotech company focused on stem cell-derived exosome therapies targeting incurable diseases. His contributions have significantly advanced both the clinical and translational neuroscience domains.

Professional profile👤

Google Scholar

ORCID

Strengths for the Awards✨

Professor Oh Young Bang stands as a global leader in the field of neurology, particularly in stroke research, neuroimaging, and stem cell-derived exosome therapy. His current roles—Professor at Samsung Medical Center, Sungkyunkwan University, and CEO of S&E Bio—showcase his academic and translational research excellence. His groundbreaking work bridges the gap between basic science and real-world clinical solutions, with a strong focus on biomarkers, risk factors, and novel therapies for incurable neurological diseases.

Bang’s publication record is exceptionally strong, with over 300 peer-reviewed SCI/SCIE papers, numerous book chapters, and participation in international multicenter clinical trials. His ability to move seamlessly from preclinical models to human trials emphasizes translational impact. His work on mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) has gained global recognition, notably for enhancing neuroplasticity post-stroke and showing scalable production methods.

Moreover, his editorial contributions to prestigious journals such as Stroke, J Stroke, and Cerebrovascular Disease, along with being Editor-in-Chief of Precision and Future Medicine, underline his thought leadership in the scientific community. The 30 patents he holds are a testament to his innovation-driven mindset and industry-aligned contributions.

🎓 Education

While specific degrees and institutions are not listed in the provided data, it is evident that Professor Bang’s academic foundation is firmly rooted in neurology and neuroscience, having led to his dual professorships and executive role in biotechnology. His advanced training has equipped him to bridge clinical neurology with innovative biotech applications.

đź’Ľ Experience

Professor Bang has built an illustrious career with extensive experience in clinical neurology, stroke research, and regenerative medicine. He actively leads preclinical and clinical stroke programs, emphasizing neuroimaging, biomarkers, risk factor analysis, and stem cell therapy. With a prolific output of over 300 SCI/SCIE-indexed articles, numerous book chapters, and 30 patents, he has played a pivotal role in global research and innovation. His leadership in international clinical trials and his contributions as a keynote speaker at global neurology and biotechnology conferences underscore his global impact.

🔬 Research Interests On Neuroscience

Professor Bang’s research focuses on stroke mechanisms, neuroimaging techniques, stem cell therapy, and biomarkers of neurological diseases. A notable aspect of his work includes advancing mesenchymal stem cell (MSC) therapy through extracellular vesicles, as well as developing scalable production methods for clinical applications. His research also investigates cancer-related thrombosis, arterial remodeling, and the neurovascular interface, making him a thought leader in translational neuroscience.

🏆 Awards & Editorial Roles

Though specific honors are not detailed, Professor Bang’s reputation is validated by his leadership roles in multiple top-tier journals. He served on the editorial boards of:

  • Stroke (2010–2015)

  • Journal of Stroke (since 2013)

  • Journal of Clinical Neurology (2006–2014)

  • Cerebrovascular Disease (2016–2019)
    Additionally, he was Editor-in-Chief of Precision and Future Medicine (2018–2022). His selection to these prestigious roles highlights his scientific influence and recognition in neurology and biomedical science.

đź“š Selected Publications

  • Randomized assessment of rapid endovascular treatment of ischemic stroke
    Authors: M Goyal, AM Demchuk, BK Menon, M Eesa, JL Rempel, J Thornton, et al.
    Year: 2015
    Citations: 7,247

  • Autologous mesenchymal stem cell transplantation in stroke patients
    Authors: OY Bang, JS Lee, PH Lee, G Lee
    Year: 2005
    Citations: 1,489

  • A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke
    Authors: JS Lee, JM Hong, GJ Moon, PH Lee, YH Ahn, OY Bang
    Year: 2010
    Citations: 941

  • Collateral flow predicts response to endovascular therapy for acute ischemic stroke
    Authors: OY Bang, JL Saver, SJ Kim, GM Kim, CS Chung, B Ovbiagele, KH Lee, et al.
    Year: 2011
    Citations: 660

  • Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
    Authors: MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, et al.
    Year: 2020
    Citations: 609

  • Longitudinal changes of resting-state functional connectivity during motor recovery after stroke
    Authors: C Park, WH Chang, SH Ohn, ST Kim, OY Bang, A Pascual-Leone, YH Kim
    Year: 2011
    Citations: 567

  • Impact of collateral flow on tissue fate in acute ischaemic stroke
    Authors: OY Bang, JL Saver, BH Buck, JR Alger, S Starkman, B Ovbiagele, D Kim, et al.
    Year: 2008
    Citations: 479

  • Stroke statistics in Korea: part I. Epidemiology and risk factors
    Authors: KS Hong, OY Bang, DW Kang, KH Yu, HJ Bae, JS Lee, JH Heo, SU Kwon, et al.
    Year: 2013
    Citations: 442

  • Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis
    Authors: BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, et al.
    Year: 2019
    Citations: 407

  • Early neutrophilia is associated with volume of ischemic tissue in acute stroke
    Authors: BH Buck, DS Liebeskind, JL Saver, OY Bang, SW Yun, S Starkman, LK Ali, et al.
    Year: 2008
    Citations: 404

  • Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
    Authors: L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, et al.
    Year: 2018
    Citations: 397

  • Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke
    Authors: OY Bang, JL Saver, SJ Kim, GM Kim, CS Chung, B Ovbiagele, KH Lee, et al.
    Year: 2011
    Citations: 364

  • The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy
    Authors: PH Lee, G Lee, HJ Park, OY Bang, IS Joo, K Huh
    Year: 2006
    Citations: 311

  • Collateral circulation in ischemic stroke: assessment tools and therapeutic strategies
    Authors: OY Bang, M Goyal, DS Liebeskind
    Year: 2015
    Citations: 305

🧾 Conclusion

Professor Oh Young Bang epitomizes excellence in translational neurology through his pioneering work in stroke research, neuroimaging, and stem cell-derived therapies. With a rare blend of academic leadership, clinical innovation, and industrial entrepreneurship, he represents a powerful force in the pursuit of solutions for some of medicine’s most intractable neurological challenges. His distinguished publications, editorial appointments, and patent portfolio collectively highlight his candidacy as a most deserving recipient of the Best Researcher Award.

Subodh Kumar | Neuroscience | Best Researcher Award

Posted on by Forensic Scientist

Assist. Prof. Dr. Subodh Kumar | Neuroscience | Best Researcher Award

Texas Tech University Health Sciences Center El Paso | United States

Dr. Subodh Kumar is an esteemed Assistant Professor in the Department of Molecular and Translational Medicine at Texas Tech University Health Sciences Center (TTUHSC), El Paso, USA. With a strong foundation in molecular biology and neurobiology, Dr. Kumar’s research centers around understanding the molecular underpinnings of neurodegenerative diseases, particularly Alzheimer’s disease (AD). He has made significant strides in uncovering the roles of synaptosomal and mitochondrial microRNAs in synaptic dysfunction and cognitive decline. A prolific researcher and innovator, Dr. Kumar has also contributed to biomarker discovery, therapeutic target identification, and translational neuroscience using cutting-edge multi-omics approaches.

Professional profile👤

Google Scholar

Scopus

Strengths for the Awards✨

Dr. Subodh Kumar has established an enviable track record of original, high-impact research that squarely meets—and arguably exceeds—the criteria for a “Best Researcher” distinction. His laboratory was first to profile synapse-localized microRNAs in the human brain and to link their deregulation to Alzheimer’s disease (AD), opening a fresh mechanistic window on synaptic failure. That foundational discovery has already yielded four first- or corresponding-author papers in top-tier journals since 2024 (e.g., Molecular Psychiatry and Clinical & Translational Medicine) and a growing citation trajectory.

Concurrently, Dr. Kumar has secured competitive funding as PI on an NIH K99/R00 Pathway to Independence Award, an R00 project running through 2026, and multiple foundation and intramural grants—clear evidence of both scientific rigor and fiscal stewardship. His service portfolio is equally compelling: associate editor for the Journal of Alzheimer’s Disease, ad-hoc reviewer for NIH, AHA, and international agencies, and manuscript referee for leading journals such as Nature Communications. Collectively, these achievements demonstrate innovation, productivity, leadership, and an ability to translate ideas into funded, peer-validated science—key hallmarks of an award-worthy researcher.

🎓 Education

Dr. Kumar’s academic journey began with a B.Sc. in Biology (2004) and an M.Sc. in Biotechnology (2005) from CCS University, Meerut, India. He earned his Ph.D. in Molecular Biology from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, in 2014. Furthering his expertise, he completed postdoctoral training in Neurobiology at TTUHSC, Lubbock, Texas, USA, in 2021. His education spans across premier institutions in India and the United States, equipping him with a solid interdisciplinary background.

🧪 Experience

Dr. Kumar holds a distinguished career spanning academia and research. He is currently an Assistant Professor at TTUHSC El Paso (2022–present) and previously served as a Research Assistant Professor and Postdoctoral Fellow at TTUHSC Lubbock. His research roots trace back to roles at PGIMER and IIMT College of Medical Science in India. He has also held influential editorial roles and served as an ad-hoc reviewer for NIH and international grant agencies. With over 15 years in scientific research, Dr. Kumar has shaped the fields of neurobiology and molecular medicine through his multifaceted experience.

🧠 Research Interests On Neuroscience

Dr. Kumar’s research is dedicated to elucidating the roles of synaptic and mitochondrial microRNAs in neurodegeneration, especially in Alzheimer’s and Parkinson’s diseases. His lab explores miRNA-mediated modulation of synaptic proteins, neurotransmission, and mitochondrial health using advanced in vivo models and omics platforms. Current projects focus on miR-502-3p as a biomarker and therapeutic target in AD, including studies in Hispanic populations. His research portfolio spans synapse plasticity, GABAergic signaling, multi-omics integration, and biomarker validation in human and animal models.

🏅 Awards

Dr. Kumar’s excellence in neuroscience and molecular biology has earned him numerous accolades, including the Marsh Foundation Research Award (2024) and the prestigious NIH Pathway to Independence Career Development Award (K99/R00, 2020). He received the Best Oral Presentation Award at TTUHSC El Paso’s Annual Research Symposium (2022) and Best Poster Award at the Regional Healthy Aging Symposium (2018). His early career was marked by top-tier fellowships from ICMR, CSIR, and IIT Kanpur. These honors underscore his impactful contributions to aging and neurodegenerative disease research.

đź“š Publications

  • Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease
    PH Reddy, M Manczak, X Yin, MC Grady, A Mitchell, S Tonk, CS Kuruva, …
    Year: 2018
    Citations: 367

  • Are circulating microRNAs peripheral biomarkers for Alzheimer’s disease?
    S Kumar, PH Reddy
    Year: 2016
    Citations: 333

  • Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease
    PH Reddy, XL Yin, M Manczak, S Kumar, JA Pradeepkiran, M Vijayan, …
    Year: 2018
    Citations: 292

  • MicroRNAs as peripheral biomarkers in aging and age-related diseases
    S Kumar, M Vijayan, JS Bhatti, PH Reddy
    Year: 2017
    Citations: 234

  • MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
    S Kumar, M Vijayan, PH Reddy
    Year: 2017
    Citations: 169

  • A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer’s disease
    PH Reddy, S Tonk, S Kumar, M Vijayan, R Kandimalla, CS Kuruva, …
    Year: 2017
    Citations: 158

  • Defective mitophagy and synaptic degeneration in Alzheimer’s disease: Focus on aging, mitochondria and synapse
    H Morton, S Kshirsagar, E Orlov, LE Bunquin, N Sawant, L Boleng, …
    Year: 2021
    Citations: 142

  • Deregulated mitochondrial microRNAs in Alzheimer’s disease: focus on synapse and mitochondria
    P Gowda, PH Reddy, S Kumar
    Year: 2022
    Citations: 121

  • MicroRNA-455-3p as a potential biomarker for Alzheimer’s disease: an update
    S Kumar, PH Reddy
    Year: 2018
    Citations: 116

  • Are microRNAs true sensors of ageing and cellular senescence?
    J Williams, F Smith, S Kumar, M Vijayan, PH Reddy
    Year: 2017
    Citations: 96

🔚 Conclusion

In conclusion, Dr. Subodh Kumar stands out as a visionary scientist whose pioneering work in Alzheimer’s disease has bridged molecular biology and translational neuroscience. His innovative studies on synaptosomal and mitochondrial miRNAs offer promising avenues for diagnostic and therapeutic advancements. Dr. Kumar’s dedication, scholarly excellence, and translational impact make him a deserving candidate for this award recognition.